Article Text

Download PDFPDF

P361 Prevalence of bacterial vaginosis among women attending sexual health clinics in new york city, 2017–2018
Free
  1. Alissa Davis1,
  2. Preeti Pathela2,
  3. Addie Crawley2,
  4. Julia Schillinger3
  1. 1Columbia University, School of Social Work, New York, USA
  2. 2New York City Department of Health and Mental Hygiene, Bureau of Sexually Transmitted Infections, New York City, USA
  3. 3Centers for Disease Control and Prevention, New York City, USA

Abstract

Background Bacterial vaginosis (BV) is a common condition among women and is associated with HIV/STI acquisition and adverse pregnancy outcomes. We describe the prevalence of BV diagnoses and repeat BV diagnoses among women attending New York City (NYC) public sexual health clinics (SHC) and examine demographic characteristics associated with BV.

Methods Using electronic medical record data for patients who were assigned female sex at birth (“women”), we identified BV diagnoses made during clinician visits at NYC SHC during January 2017–April 2018, and recurrent BV during a six-month follow-up period through October 2018. BV diagnosis was defined as a physician diagnosis of BV with a vaginal pH ≥4.5, and positive whiff-amine test. We used chi-square tests to compare characteristics of women with and without a BV diagnosis.

Results Of 13,153 women with 1 visits to the SHC, 34% (4,449) were diagnosed with BV. There were significant differences in BV prevalence by race/ethnicity: 39.5% (95% CI: [38.7–40.3%]) of non-Hispanic black women versus 29.6% ([28.3–30.9%]) Hispanic, 21.2% ([19.1–23.3%]) non-Hispanic white, and 19.7% ([16.5–22.9%]) non-Hispanic Asian women. Women of HIV-negative/unknown HIV status had higher BV prevalence than HIV-positive women (33.9% vs 23.4%, p=0.02). Women reporting sex with both men and women had higher BV prevalence (42.0%, 95% CI: [37.5–46.5%]) than women reporting sex with men only (34.5%, [34.2–34.8%]) or women reporting sex with women only (28.1%, [22.2–34.0%]). Among women with BV, 4,404 (99%) received treatment and 1588 (36.1%) of those had another clinician visit within 6 months. Among returning women, 282 (17.8%) were given another BV diagnosis within 3 months, and 601 (37.8%) within 6 months.

Conclusion One-third of women attending NYC SHC were diagnosed with BV, and recurrent BV was common. Additional research is needed to identify effective therapies to reduce the high prevalence and recurrence rates of BV.

Disclosure No significant relationships.

  • vaginal infections and dysbiosis
  • modeling and prevalence

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.